Literature DB >> 12740268

Community-acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients.

Anan Wattanathum1, Chutima Chaoprasong, Pongpun Nunthapisud, Sudaluck Chantaratchada, Nukool Limpairojn, Anon Jatakanon, Nonglak Chanthadisai.   

Abstract

STUDY
OBJECTIVES: To determine microbial agents causing community-acquired pneumonia (CAP) in Southeast Asia.
DESIGN: A prospective study.
SETTING: Three general hospitals in Thailand. PATIENTS: Two hundred forty-five adult patients fulfilling the clinical criteria of CAP from September 1998 to April 2001.
INTERVENTIONS: Investigations included sputum Gram stain and culture, blood culture, pleural fluid culture (if presented), urine antigen for Legionella pneumophila and Streptococcus pneumoniae, and serology for Mycoplasma pneumoniae, Chlamydia pneumoniae, and L pneumophila.
RESULTS: There were 98 outpatients and 147 hospitalized patients included in the study, and an organism was identified in 74 of 98 outpatients (75.5%) and 105 of 147 of the hospitalized patients (71.4%). C pneumoniae (36.7%), M pneumoniae (29.6%), and S pneumoniae (13.3%) were the most frequent causative pathogens found in outpatients, while S pneumoniae (22.4%) and C pneumoniae (16.3%) were the most common in hospitalized patients. There was a significantly higher incidence of C pneumoniae (36.7% vs 16.3%, respectively; p < 0.001) and M pneumoniae (29.6% vs 6.8%; p < 0.001, respectively) in the outpatients than in the hospitalized patients. The incidence of S pneumoniae, L pneumophila, and mixed infections was not different between the groups. Mixed infections were presented in 13 of 98 outpatients (13.3%) and 9 of 147 hospitalized patients (6.1%), with C pneumoniae being the most frequent coinfecting pathogen.
CONCLUSIONS: The data indicate that the core organisms causing CAP in Southeast Asia are not different from those in the Western countries. The guidelines for the treatment of patients with CAP, therefore, should be the same.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740268     DOI: 10.1378/chest.123.5.1512

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Molecular Characterization of Mycoplasma pneumoniae Infections in Two Rural Populations of Thailand from 2009 to 2012.

Authors:  Toni Whistler; Pongpun Sawatwong; Maureen H Diaz; Alvaro J Benitez; Bernard J Wolff; Patranuch Sapchookul; Somsak Thamthitiwat; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

Review 3.  [Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections].

Authors:  O Leroy
Journal:  Med Mal Infect       Date:  2006-11-13       Impact factor: 2.152

4.  A prospective study of inpatients to determine microbial etiology and therapeutic outcome of antibiotics for community-acquired pneumonia in pakistan.

Authors:  Sahar Rehman; Kanwal Rehman; Muhammad Sajid Hamid Akash
Journal:  Bioimpacts       Date:  2013-06-23

5.  Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis.

Authors:  Takashi Hirama; Takefumi Yamaguchi; Hitoshi Miyazawa; Tomoaki Tanaka; Giichi Hashikita; Etsuko Kishi; Yoshimi Tachi; Shun Takahashi; Keiji Kodama; Hiroshi Egashira; Akemi Yokote; Kunihiko Kobayashi; Makoto Nagata; Toshiaki Ishii; Manabu Nemoto; Masahiko Tanaka; Koichi Fukunaga; Satoshi Morita; Minoru Kanazawa; Koichi Hagiwara
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

Review 6.  Pneumonia in South-East Asia Region: public health perspective.

Authors:  M Ghimire; S K Bhattacharya; J P Narain
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

Review 7.  Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.

Authors:  Kay Wang; Peter Gill; Rafael Perera; Anne Thomson; David Mant; Anthony Harnden
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

8.  Homology modeling of Mycoplasma pneumoniae enolase and its molecular interaction with human plasminogen.

Authors:  Vasunun Chumchua; Natapol Pornputtapong; Chinae Thammarongtham; Duangdeun Meksuriyen
Journal:  Bioinformation       Date:  2008-09-08

9.  Bacteria Etiological Agents Causing Lower Respiratory Tract Infections and Their Resistance Patterns.

Authors:  Salman Khan; Singh Priti; Sachan Ankit
Journal:  Iran Biomed J       Date:  2015-07-29

10.  The incidence and aetiology of hospitalised community-acquired pneumonia among Vietnamese adults: a prospective surveillance in Central Vietnam.

Authors:  Kensuke Takahashi; Motoi Suzuki; Le Nhat Minh; Nguyen Hien Anh; Luu Thi Minh Huong; Tran Vo Vinh Son; Phan The Long; Nguyen Thi Thuy Ai; Le Huu Tho; Konosuke Morimoto; Paul E Kilgore; Dang Duc Anh; Koya Ariyoshi; Lay Myint Yoshida
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.